Roderick H. O'Reilly - Feb 28, 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role: Director
Signature: /s/ Todd Holvick, Attorney-in-Fact
Stock symbol: AUGX
Transactions as of: Feb 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/2/2023, 04:01 PM
Previous filing: Dec 30, 2021
Next filing: Jul 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Employee Stock Option (right to buy)	Award	$0	+370K		$0.00	370K	Feb 28, 2023	Common Stock	370K	$1.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the grant date and the remaining shares subject to the Option shall vest subsequently in thirty-six (36) equal monthly increments, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Content

The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the grant date and the remaining shares subject to the Option shall vest subsequently in thirty-six (36) equal monthly increments, subject to the Reporting Person's provision of service to the Issuer on each vesting date.